Best Practice & Research Clinical Endocrinology & Metabolism
Volume 20, Issue 4 , Pages 611-626 , December 2006

Glucocorticoid resistance syndrome: a diagnostic and therapeutic approach

  • Elisabeth F.C. van Rossum, MD, PhD (Resident in Internal Medicine)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +31 10 4639222; Fax: +31 10 4635430.

References 

  1. Charmandari E, Kino T, Chrousos GP. Familial/sporadic glucocorticoid resistance: clinical phenotype and molecular mechanisms. Annals of the New York Academy of Sciences. 2004;1024:168–181
  2. Lamberts SW, Koper JW, Biemond P, et al. Cortisol receptor resistance: the variability of its clinical presentation and response to treatment. The Journal of Clinical Endocrinology and Metabolism. 1992;74:313–321
  3. Chrousos GP, Gold PW. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA. 1992;267:1244–1252
  4. Taylor AL, Fishman LM. Corticotropin-releasing hormone. The New England Journal of Medicine. 1988;319:213–222
  5. Antoni FA. Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor. Endocrine Reviews. 1986;7:351–378
  6. Lundblad JR, Roberts JL. Regulation of proopiomelanocortin gene expression in pituitary. Endocrine Reviews. 1988;9:135–158
  7. Bronnegard M, Werner S, Gustafsson JA. Primary cortisol resistance associated with a thermolabile glucocorticoid receptor in a patient with fatigue as the only symptom. The Journal of Clinical Investigation. 1986;78:1270–1278
  8. Vingerhoeds AC, Thijssen JH, Schwarz F. Spontaneous hypercortisolism without Cushing's syndrome. The Journal of Clinical Endocrinology and Metabolism. 1976;43:1128–1133
  9. Hurley DM, Accili D, Stratakis CA, et al. Point mutation causing a single amino acid substitution in the hormone binding domain of the glucocorticoid receptor in familial glucocorticoid resistance. The Journal of Clinical Investigation. 1991;87:680–686
  10. Brufsky AM, Malchoff DM, Javier EC, et al. A glucocorticoid receptor mutation in a subject with primary cortisol resistance. Transactions of the Association of American Physicians. 1990;103:53–63
  11. Ruiz M, Lind U, Gafvels M, et al. Characterization of two novel mutations in the glucocorticoid receptor gene in patients with primary cortisol resistance. Clinical Endocrinology. 2001;55:363–371
  12. Malchoff DM, Brufsky A, Reardon G, et al. A mutation of the glucocorticoid receptor in primary cortisol resistance. The Journal of Clinical Investigation. 1993;91:1918–1925
  13. Karl M, Lamberts SW, Detera-Wadleigh SD, et al. Familial glucocorticoid resistance caused by a splice site deletion in the human glucocorticoid receptor gene. The Journal of Clinical Endocrinology and Metabolism. 1993;76:683–689
  14. Karl M, Lamberts SW, Koper JW, et al. Cushing's disease preceded by generalized glucocorticoid resistance: clinical consequences of a novel, dominant-negative glucocorticoid receptor mutation. Proceedings of the Association of American Physicians. 1996;108:296–307
  15. Mendonca BB, Leite MV, de Castro M, et al. Female pseudohermaphroditism caused by a novel homozygous missense mutation of the GR gene. The Journal of Clinical Endocrinology and Metabolism. 2002;87:1805–1809
  16. Vottero A, Kino T, Combe H, et al. A novel, C-terminal dominant negative mutation of the GR causes familial glucocorticoid resistance through abnormal interactions with p160 steroid receptor coactivators. The Journal of Clinical Endocrinology and Metabolism. 2002;87:2658–2667
  17. Charmandari E, Raji A, Kino T, et al. A novel point mutation in the ligand-binding domain (LBD) of the human glucocorticoid receptor (hGR) causing generalized glucocorticoid resistance: the importance of the C terminus of hGR LBD in conferring transactivational activity. The Journal of Clinical Endocrinology and Metabolism. 2005;90:3696–3705
  18. Russcher H, Smit P, van Rossum EF, et al. Strategies for the characterization of disorders in cortisol sensitivity. The Journal of Clinical Endocrinology and Metabolism. 2006;91:694–701
  19. Lamberts SW. Hereditary glucocorticoid resistance. Annales d'endocrinologie. 2001;62:164–167
  20. Charmandari E, Kino T, Ichijo T, et al. Functional characterization of the natural human glucocorticoid receptor (hGR) mutants hGRalphaR477H and hGRalphaG679S associated with generalized glucocorticoid resistance. The Journal of Clinical Endocrinology and Metabolism. 2006;91:1535–1543
  21. de Lange P, Koper JW, Huizenga NA, et al. Differential hormone-dependent transcriptional activation and -repression by naturally occurring human glucocorticoid receptor variants. Molecular Endocrinology. 1997;11:1156–1164
  22. Leung DY, Hamid Q, Vottero A, et al. Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor beta. The Journal of Experimental Medicine. 1997;186:1567–1574
  23. de Lange P, Segeren CM, Koper JW, et al. Expression in hematological malignancies of a glucocorticoid receptor splice variant that augments glucocorticoid receptor-mediated effects in transfected cells. Cancer Research. 2001;61:3937–3941
  24. Iida S, Gomi M, Moriwaki K, et al. Primary cortisol resistance accompanied by a reduction in glucocorticoid receptors in two members of the same family. The Journal of Clinical Endocrinology and Metabolism. 1985;60:967–971
  25. Nawata H, Sekiya K, Higuchi K, et al. Decreased deoxyribonucleic acid binding of glucocorticoid-receptor complex in cultured skin fibroblasts from a patient with the glucocorticoid resistance syndrome. The Journal of Clinical Endocrinology and Metabolism. 1987;65:219–226
  26. Vecsei P, Frank K, Haack D, et al. Primary glucocorticoid receptor defect with likely familial involvement. Cancer Research. 1989;49:2220s–2221s
  27. Drigo I, Saccari A, Bacchin C, et al. Glucocorticoid resistance in a girl with Takayasu's arteritis. Annals of the Rheumatic Diseases. 2006;65:689–691
  28. Bamberger CM, Schulte HM, Chrousos GP. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocrine Reviews. 1996;17:245–261
  29. Iida S, Nakamura Y, Fujii H, et al. A patient with hypocortisolism and Cushing's syndrome-like manifestations: cortisol hyperreactive syndrome. The Journal of Clinical Endocrinology and Metabolism. 1990;70:729–737
  30. Newfield RS, Kalaitzoglou G, Licholai T, et al. Normocortisolemic Cushing's syndrome initially presenting with increased glucocorticoid receptor numbers. The Journal of Clinical Endocrinology and Metabolism. 2000;85:14–21
  31. Huizenga NA, de Lange P, Koper JW, et al. Five patients with biochemical and/or clinical generalized glucocorticoid resistance without alterations in the glucocorticoid receptor gene. The Journal of Clinical Endocrinology and Metabolism. 2000;85:2076–2081
  32. van Rossum EFC, Koper JW, Huizenga NA, et al. A polymorphism in the glucocorticoid receptor gene, which decreases sensitivity to glucocorticoids in vivo, is associated with low insulin and cholesterol levels. Diabetes. 2002;51:3128–3134
  33. Russcher H, Smit P, van den Akker EL, et al. Two polymorphisms in the glucocorticoid receptor gene directly affect glucocorticoid-regulated gene expression. The Journal of Clinical Endocrinology and Metabolism. 2005;90:5804–5810
  34. Pratt WB. The role of heat shock proteins in regulating the function, folding, and trafficking of the glucocorticoid receptor. The Journal of Biological Chemistry. 1993;268:21455–21458
  35. Kang KI, Meng X, Devin-Leclerc J, et al. The molecular chaperone Hsp90 can negatively regulate the activity of a glucocorticosteroid-dependent promoter. Proceedings of the National Academy of Sciences of the USA. 1999;96:1439–1444
  36. Bronnegard M, Boos J, Marcus C, et al. Expression of hsp90 beta messenger ribonucleic acid in patients with familial glucocorticoid resistance–correlation to receptor status. The Journal of Steroid Biochemistry and Molecular Biology. 1995;52:345–349
  37. Gaitan D, DeBold CR, Turney MK, et al. Glucocorticoid receptor structure and function in an adrenocorticotropin-secreting small cell lung cancer. Molecular Endocrinology. 1995;9:1193–1201
  38. Karl M, Von Wichert G, Kempter E, et al. Nelson's syndrome associated with a somatic frame shift mutation in the glucocorticoid receptor gene. The Journal of Clinical Endocrinology and Metabolism. 1996;81:124–129
  39. Palmer LA, Hukku B, Harmon JM. Human glucocorticoid receptor gene deletion following exposure to cancer chemotherapeutic drugs and chemical mutagens. Cancer Research. 1992;52:6612–6618
  40. Hillmann AG, Ramdas J, Multanen K, et al. Glucocorticoid receptor gene mutations in leukemic cells acquired in vitro and in vivo. Cancer Research. 2000;60:2056–2062
  41. Pariante CM. Glucocorticoid receptor function in vitro in patients with major depression. Stress. 2004;7:209–219
  42. Sher E, Leung D, Surs W, et al. Steroid resistant asthma: Cellular mechanisms contributing to inadequate response to glucocorticoid therapy. Journal of Clinical Investigation. 1995;93:33–39
  43. Ito K, Chung KF, Adcock IM. Update on glucocorticoid action and resistance. The Journal of Allergy and Clinical Immunology. 2006;117:522–543
  44. Chikanza IC, Petrou P, Kingsley G, et al. Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthritis and Rheumatism. 1992;35:1281–1288
  45. Munkholm P, Langholz E, Davidsen M, Binder V. Frequency of glucocorticoid resistance and dependency in Crohn's disease. Gut. 1994;35:360–362
  46. Rai T, Ohira H, Tojo J, et al. Expression of human glucocorticoid receptor in lymphocytes of patients with autoimmune hepatitis. Hepatology Research. 2004;29:148–152
  47. Norbiato G, Bevilacqua M, Vago T, et al. Cortisol resistance in acquired immunodeficiency syndrome. The Journal of Clinical Endocrinology and Metabolism. 1992;74:608–613
  48. Lamberts SW. Glucocorticoid receptors and Cushing's disease. Molecular and Cellular Endocrinology. 2002;197:69–72
  49. Huizenga NA, De Herder WW, Koper JW, et al. Decreased ligand affinity rather than glucocorticoid receptor down-regulation in patients with endogenous Cushing's syndrome. European Journal of Endocrinology. 2000;142:472–476
  50. Molijn GJ, Spek JJ, van Uffelen JC, et al. Differential adaptation of glucocorticoid sensitivity of peripheral blood mononuclear leukocytes in patients with sepsis or septic shock. The Journal of Clinical Endocrinology and Metabolism. 1995;80:1799–1803
  51. Lamberts SW, Koper JW, de Jong FH. The endocrine effects of long-term treatment with mifepristone (RU 486). The Journal of Clinical Endocrinology and Metabolism. 1991;73:187–191
  52. Jiang T, Liu S, Tan M, et al. The phase-shift mutation in the glucocorticoid receptor gene: potential etiologic significance of neuroendocrine mechanisms in lupus nephritis. Clinica Chimica Acta. 2001;313:113–117
  53. Lane SJ, Arm JP, Staynov DZ, et al. Chemical mutational analysis of the human glucocorticoid receptor cDNA in glucocorticoid-resistant bronchial asthma. American Journal of Respiratory Cell and Molecular Biology. 1994;11:42–48
  54. Sousa AR, Lane SJ, Cidlowski JA, et al. Glucocorticoid resistance in asthma is associated with elevated in vivo expression of the glucocorticoid receptor beta-isoform. The Journal of Allergy and Clinical Immunology. 2000;105:943–950
  55. Goleva E, Li LB, Eves PT, et al. Increased glucocorticoid receptor beta alters steroid response in glucocorticoid-insensitive asthma. American Journal of Respiratory and Critical Care Medicine. 2006;173:607–616
  56. Leung DY, Spahn JD, Szefler SJ. Immunologic basis and management of steroid-resistant asthma. Allergy and Asthma Proceedings. 1999;20:9–14
  57. Irusen E, Matthews JG, Takahashi A, et al. p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma. The Journal of Allergy and Clinical Immunology. 2002;109:649–657
  58. Matthews JG, Ito K, Barnes PJ, Adcock IM. Defective glucocorticoid receptor nuclear translocation and altered histone acetylation patterns in glucocorticoid-resistant patients. The Journal of Allergy and Clinical Immunology. 2004;113:1100–1108
  59. Kariagina A, Zonis S, Afkhami M, et al. Leukemia inhibitory factor regulates glucocorticoid receptor expression in the hypothalamic-pituitary-adrenal axis. American Journal of Physiology. Endocrinology and metabolism. 2005;289:E857–E863
  60. Huizenga NA, Koper JW, de Lange P, et al. Interperson variability but intraperson stability of baseline plasma cortisol concentrations, and its relation to feedback sensitivity of the hypothalamo-pituitary-adrenal axis to a low dose of dexamethasone in elderly individuals. Journal of Clinical Endocrinology and Metabolism. 1998;83:47–54
  61. Chriguer RS, Elias LL, da Silva IM. Jr., et al. Glucocorticoid sensitivity in young healthy individuals: in vitro and in vivo studies. The Journal of Clinical Endocrinology and Metabolism. 2005;90:5978–5984
  62. van Rossum EFC, Lamberts SWJ. Polymorphisms in the glucocorticoid receptor gene and their associations with metabolic parameters and body composition. Recent Progress in Hormone Research. 2004;59:333–357
  63. van Rossum EFC, Voorhoeve PG, te Velde SJ, et al. The ER22/23EK Polymorphism in the Glucocorticoid Receptor Gene is Associated with a Beneficial Body Composition and Muscle Strength in Young Adults. The Journal of Clinical Endocrinology and Metabolism. 2004;89:4004–4009
  64. Kuningas M, Mooijaart SP, Slagboom PE, et al. Genetic variants in the glucocorticoid receptor gene (NR3C1) and cardiovascular disease risk. The Leiden 85-plus Study. Biogerontology. 2006;
  65. van Rossum EFC, Feelders RA, Van Den Beld AW, et al. Association of the ER22/23EK polymorphism in the glucocorticoid receptor gene with survival and C-reactive protein levels in elderly men. The American Journal of Medicine. 2004;117:158–162
  66. Russcher H, van Rossum EF, de Jong FH, et al. Increased expression of the glucocorticoid receptor-A translational isoform as a result of the ER22/23EK polymorphism. Molecular Endocrinology. 2005;19:1687–1696
  67. Yudt MR, Cidlowski JA. Molecular identification and characterization of a and b forms of the glucocorticoid receptor. Molecular Endocrinology. 2001;15:1093–1103
  68. Bamberger CM, Bamberger AM, de Castro M, et al. Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. The Journal of Clinical Investigation. 1995;95:2435–2441
  69. Oakley RH, Sar M, Cidlowski JA. The human glucocorticoid receptor beta isoform. Expression, biochemical properties, and putative function. The Journal of Biological Chemistry. 1996;271:9550–9559
  70. Derijk RH, Schaaf MJ, Turner G, et al. A human glucocorticoid receptor gene variant that increases the stability of the glucocorticoid receptor beta-isoform mRNA is associated with rheumatoid arthritis. The Journal of Rheumatology. 2001;28:2383–2388
  71. Stevens A, Ray DW, Zeggini E, et al. Glucocorticoid sensitivity is determined by a specific glucocorticoid receptor haplotype. The Journal of Clinical Endocrinology and Metabolism. 2004;89:892–897
  72. van den Akker EL, Russcher H, van Rossum EF, et al. Glucocorticoid Receptor Polymorphism affects Transrepression but not Transactivation. The Journal of Clinical Endocrinology and Metabolism. 2006;
  73. Detera-Wadleigh S, Encio I, DY R, et al. A TthIIII polymorphism on the 5'-flanking region of the glucocorticoid receptor gene (GRL). Nucleic Acids Research. 1991;19:1960
  74. Rosmond R, Chagnon YC, Chagnon M, et al. A polymorphism of the 5'-flanking region of the glucocorticoid receptor gene locus is associated with basal cortisol secretion in men. Metabolism. 2000;49:1197–1199
  75. van Rossum EFC, Roks PH, de Jong FH, et al. Characterization of a promoter polymorphism in the glucocorticoid receptor gene and its relationship to three other polymorphisms. Clinical Endocrinology. 2004;61:573–581
  76. Ye JW, Ding J, Huang JP, et al. Analysis on association of glucocorticoid receptor gene polymorphism with steroid-resistance in idiopathic nephrotic syndrome of children. Zhonghua er ke za zhi. (Chinese Journal of Pediatrics), 2003;41:661–665
  77. Chrousos GP, Vingerhoeds A, Brandon D, et al. Primary cortisol resistance in man. A glucocorticoid receptor-mediated disease. The Journal of Clinical Investigation. 1982;69:1261–1269
  78. Lamberts SW, Poldermans D, Zweens M, de Jong FH. Familial cortisol resistance: differential diagnostic and therapeutic aspects. The Journal of Clinical Endocrinology and Metabolism. 1986;63:1328–1333
  79. Koper JW, Stolk RP, de Lange P, et al. Lack of association between five polymorphisms in the human glucocorticoid receptor gene and glucocorticoid resistance. Human Genetics. 1997;99:663–668
  80. ter Borg PC, Hagendorf A, van Buuren HR, et al. A pilot study exploring the role of glucocorticoid receptor variants in primary biliary cirrhosis and primary sclerosing cholangitis. The Netherlands Journal of Medicine. 2004;62:326–331
  81. Smit P, Russcher H, de Jong FH, et al. Differential regulation of synthetic glucocorticoids on gene expression levels of glucocorticoid-induced leucine zipper and interleukin-2. The Journal of Clinical Endocrinology and Metabolism. 2005;90:2994–3000
  82. Tomita M, Brandon DD, Chrousos GP, et al. Glucocorticoid receptors in Epstein-Barr virus-transformed lymphocytes from patients with glucocorticoid resistance and a glucocorticoid-resistant New World primate species. The Journal of Clinical Endocrinology and Metabolism. 1986;62:1145–1154
  83. Kino T, Stauber RH, Resau JH, et al. Pathologic human GR mutant has a transdominant negative effect on the wild-type GR by inhibiting its translocation into the nucleus: importance of the ligand-binding domain for intracellular GR trafficking. The Journal of Clinical Endocrinology and Metabolism. 2001;86:5600–5608
  84. Charmandari E, Kino T, Souvatzoglou E, et al. Natural glucocorticoid receptor mutants causing generalized glucocorticoid resistance: molecular genotype, genetic transmission, and clinical phenotype. The Journal of Clinical Endocrinology and Metabolism. 2004;89:1939–1949

PII: S1521-690X(06)00076-5

doi: 10.1016/j.beem.2006.09.005

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 20, Issue 4 , Pages 611-626 , December 2006

Article Tools

* Image Usage & Resolution